-Inclusion.in There is good news. And there’s bad news. The good news first. There’s been a bumper wheat crop and the granaries are overflowing. And the bad news? Where do we begin? A lot of that grain will rot. Millions will still remain hungry. Heavily in debt and distressed, farmers are committing suicide. Food prices are soaring. There’s more… Farmers don’t have money. Their land is too small and isn’t yielding much. Fertilisers and...

-Down to Earth As corruption hijacks procurement centres in Bundelkhand, farmers prefer suicide to a debt trap. Richard Mahapatra reports from Uttar Pradesh with photographer Sayantoni Palchoudhuri A fatal paradox strikes Bundelkhand in the face—an overflowing wheat stock yet an overwhelming number of farmer suicides. Farmers here dread the government wheat procurement centre and the post-mortem house. In Orai, a small town in the Bundelkhand region of Uttar Pradesh, the two are...

-The Hindu Commodification, commercialisation and financialisation of nature will produce a greedy, not green, economy Over 100 world leaders will meet in Rio de Janeiro this week for the U.N. Conference on Sustainable Development, popularly referred to as Rio+20 Global Earth Summit. It is being held amidst “‘a world running low on drinking water and productive land’ and set against the backdrop of accelerating global warming, climate change, chemical contamination of air, land...

-The Hindu The United Nations Conference on Sustainable Development (Rio+20) is set to take place on June 20 at Rio de Janeiro, 20 years after the 1992 Earth Summit on Environment & Development. World leaders, experts, and U.N. agencies are expected to take stock and reaffirm global commitment to sustainable development. The summit is taking place against the backdrop of threats of catastrophic climate change, unprecedented environmental degradation and widespread market...

-The Economic Times   Pushed to the wall by an overly cautious drug regulator and an alarmist Indian government, clinical trial companies are looking at South East Asian countries to expand their business and escape the red tape of Indian authorities.  Clinical research companies (CROs), that were aspiring to become billion- dollar companies by 2010, had to rework their plans after a Parliamentary Standing Committee report questioned the allegedly unfair and unethical trials...